Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia

International Journal of Antimicrobial Agents

Volumn 18, Issue 6, 2001, Pages 547-551

  Visconti, E ^a   Ortona, E ^b   Mencarini, P ^a   Margutti, P ^b   Marinaci, S ^a   Zolfo, M ^a   Siracusano, A ^b   Tamburrini, Enrica ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Mutations of dihydropteroate synthase gene (DHPS); Pneumocystis carinii; Sulpha sulphone drugs

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; COTRIMOXAZOLE; DIDANOSINE; DIHYDROPTEROATE SYNTHASE; MALOPRIM; PENTAMIDINE; PREDNISONE; PRIMAQUINE; SULFONE; TRIMETREXATE; ZIDOVUDINE;

ADULT; ARTICLE; BACTERIUM COLONY; BACTERIUM ISOLATION; BACTERIUM MUTANT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MEGADOSE; ENZYME ASSAY; FEMALE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LUNG LAVAGE; MALE; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TREATMENT FAILURE;

ADULT; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MUTATION; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; SULFONES; TREATMENT FAILURE;

EID: 0035217101     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00460-5     Document Type: Article

References (19)

1. Dihydropteroate synthase polymorphisms in Pneumocystis carinii
2. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthatase by sulfa drugs
3. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase:dihydropteroase synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine
4. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients
5. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene
6. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use
7. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia
8. Association between Pneumocystis carinii prophylaxis, P. carinii molecular genotype, and clinical outcome
9. Detection of Pneumocystis carinii DNA in blood by PCR is not of value for diagnosis of P. carinii pneumonia
10. Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia
11. Aerosolized pentamidine, cotrimoxazole, and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis
12. Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme
13. Folate antagonists in the treatment of Pneumocystis carinii pneumonia
14. Inhibition of topoisomerases from Pneumocystis carinii by aromatic dicationic molecules
15. Typing with internal transcribed spacer regions of P. carinii from AIDS patients with recurrent pneumonia
16. Biodiversity of Pneumocystis carinii hominis: Typing with different DNA regions
17. Genetic variation in Pneumocystis carinii isolates from different geographic regions: Implications for transmission
18. Which opportunistic illnesses occur in the era of HAART and at what CD4 cell counts
19. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era